261 related articles for article (PubMed ID: 19930682)
21. Y-box protein-1/p18 as novel serum marker for ovarian cancer diagnosis: A study by the Tumor Bank Ovarian Cancer (TOC).
Rohr I; Braicu EI; En-Nia A; Heinrich M; Richter R; Chekerov R; Dechend R; Heidecke H; Dragun D; Schäfer R; Gorny X; Lindquist JA; Brandt S; Sehouli J; Mertens PR
Cytokine; 2016 Sep; 85():157-64. PubMed ID: 27371774
[TBL] [Abstract][Full Text] [Related]
22. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma.
Oda Y; Sakamoto A; Shinohara N; Ohga T; Uchiumi T; Kohno K; Tsuneyoshi M; Kuwano M; Iwamoto Y
Clin Cancer Res; 1998 Sep; 4(9):2273-7. PubMed ID: 9748149
[TBL] [Abstract][Full Text] [Related]
23. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
Kamura T; Yahata H; Amada S; Ogawa S; Sonoda T; Kobayashi H; Mitsumoto M; Kohno K; Kuwano M; Nakano H
Cancer; 1999 Jun; 85(11):2450-4. PubMed ID: 10357417
[TBL] [Abstract][Full Text] [Related]
24. High expression of Y-box-binding protein 1 is associated with local recurrence and predicts poor outcome in patients with colorectal cancer.
Yan X; Yan L; Zhou J; Liu S; Shan Z; Jiang C; Tian Y; Jin Z
Int J Clin Exp Pathol; 2014; 7(12):8715-23. PubMed ID: 25674237
[TBL] [Abstract][Full Text] [Related]
25. Overexpression of SERBP1 (Plasminogen activator inhibitor 1 RNA binding protein) in human breast cancer is correlated with favourable prognosis.
Serce NB; Boesl A; Klaman I; von Serényi S; Noetzel E; Press MF; Dimmler A; Hartmann A; Sehouli J; Knuechel R; Beckmann MW; Fasching PA; Dahl E
BMC Cancer; 2012 Dec; 12():597. PubMed ID: 23236990
[TBL] [Abstract][Full Text] [Related]
26. Nuclear and cytoplasmic expression of ERbeta1, ERbeta2, and ERbeta5 identifies distinct prognostic outcome for breast cancer patients.
Shaaban AM; Green AR; Karthik S; Alizadeh Y; Hughes TA; Harkins L; Ellis IO; Robertson JF; Paish EC; Saunders PT; Groome NP; Speirs V
Clin Cancer Res; 2008 Aug; 14(16):5228-35. PubMed ID: 18698041
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.
Shao F; Guo T; Chua PJ; Tang L; Thike AA; Tan PH; Bay BH; Baeg GH
Histopathology; 2015 Nov; 67(5):709-18. PubMed ID: 25817822
[TBL] [Abstract][Full Text] [Related]
28. Nuclear expression of Y-box-binding protein-1 correlates with P-glycoprotein and topoisomerase II alpha expression, and with poor prognosis in synovial sarcoma.
Oda Y; Ohishi Y; Saito T; Hinoshita E; Uchiumi T; Kinukawa N; Iwamoto Y; Kohno K; Kuwano M; Tsuneyoshi M
J Pathol; 2003 Feb; 199(2):251-8. PubMed ID: 12533839
[TBL] [Abstract][Full Text] [Related]
29. Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma.
Saji H; Toi M; Saji S; Koike M; Kohno K; Kuwano M
Cancer Lett; 2003 Feb; 190(2):191-7. PubMed ID: 12565174
[TBL] [Abstract][Full Text] [Related]
30. High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different origin.
Tacke F; Galm O; Kanig N; Yagmur E; Brandt S; Lindquist JA; Eberhardt CS; Raffetseder U; Mertens PR
BMC Cancer; 2014 Jan; 14():33. PubMed ID: 24443788
[TBL] [Abstract][Full Text] [Related]
31. [Determination of the amount of YB-1 gene mRNA in the breast tumor tissues to predict the course of disease].
Gens GP; Moiseeva NI; Stromskaia TP; Rybalkina EIu; Vaĭman AV; Stavrovskaia AA
Klin Lab Diagn; 2010 Feb; (2):29-32. PubMed ID: 20397575
[TBL] [Abstract][Full Text] [Related]
32. Histone demethylase GASC1--a potential prognostic and predictive marker in invasive breast cancer.
Berdel B; Nieminen K; Soini Y; Tengström M; Malinen M; Kosma VM; Palvimo JJ; Mannermaa A
BMC Cancer; 2012 Nov; 12():516. PubMed ID: 23148692
[TBL] [Abstract][Full Text] [Related]
33. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
34. The expression of activated Y-box binding protein-1 serine 102 mediates trastuzumab resistance in breast cancer cells by increasing CD44+ cells.
Dhillon J; Astanehe A; Lee C; Fotovati A; Hu K; Dunn SE
Oncogene; 2010 Nov; 29(47):6294-300. PubMed ID: 20802512
[TBL] [Abstract][Full Text] [Related]
35. The Y-box binding protein YB-1 is associated with progressive disease and mediates survival and drug resistance in multiple myeloma.
Chatterjee M; Rancso C; Stühmer T; Eckstein N; Andrulis M; Gerecke C; Lorentz H; Royer HD; Bargou RC
Blood; 2008 Apr; 111(7):3714-22. PubMed ID: 18006704
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of a novel monoclonal antibody against tumor-associated MUC1 for diagnosis and prognosis of breast cancer.
Stergiou N; Nagel J; Pektor S; Heimes AS; Jäkel J; Brenner W; Schmidt M; Miederer M; Kunz H; Roesch F; Schmitt E
Int J Med Sci; 2019; 16(9):1188-1198. PubMed ID: 31588183
[TBL] [Abstract][Full Text] [Related]
37. Increased nuclear localization of transcription factor Y-box binding protein 1 accompanied by up-regulation of P-glycoprotein in breast cancer pretreated with paclitaxel.
Fujita T; Ito K; Izumi H; Kimura M; Sano M; Nakagomi H; Maeno K; Hama Y; Shingu K; Tsuchiya S; Kohno K; Fujimori M
Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8837-44. PubMed ID: 16361573
[TBL] [Abstract][Full Text] [Related]
38. Expression of Y-box-binding protein YB-1 allows stratification into long- and short-term survivors of head and neck cancer patients.
Kolk A; Jubitz N; Mengele K; Mantwill K; Bissinger O; Schmitt M; Kremer M; Holm PS
Br J Cancer; 2011 Dec; 105(12):1864-73. PubMed ID: 22095225
[TBL] [Abstract][Full Text] [Related]
39. The proapoptotic molecule BLID interacts with Bcl-XL and its downregulation in breast cancer correlates with poor disease-free and overall survival.
Broustas CG; Ross JS; Yang Q; Sheehan CE; Riggins R; Noone AM; Haddad BR; Seillier-Moiseiwitsch F; Kallakury BV; Haffty BG; Clarke R; Kasid UN
Clin Cancer Res; 2010 Jun; 16(11):2939-48. PubMed ID: 20400521
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of Dicer expression in human breast cancers and association with the mesenchymal phenotype.
Grelier G; Voirin N; Ay AS; Cox DG; Chabaud S; Treilleux I; Léon-Goddard S; Rimokh R; Mikaelian I; Venoux C; Puisieux A; Lasset C; Moyret-Lalle C
Br J Cancer; 2009 Aug; 101(4):673-83. PubMed ID: 19672267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
